Massimo T. Federico

Modena, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 209 publications

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Journal: HemaSphere
Published: April 14, 2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Journal: Haematologica
Published: April 12, 2026

Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Journal: Leukemia & lymphoma
Published: March 14, 2026

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

Journal: JAMA oncology
Published: February 26, 2026

Treatment of Burkitt lymphoma in real-world setting: findings on 104 consecutive cases diagnosed and treated in Kazakhstan over the last decade.

Treatment of Burkitt lymphoma in real-world setting: findings on 104 consecutive cases diagnosed and treated in Kazakhstan over the last decade.

Journal: Annals of hematology
Published: January 12, 2026

Proteolysis targeting chimeric-based technology in myeloma and lymphoma.

Proteolysis targeting chimeric-based technology in myeloma and lymphoma.

Journal: Molecular cancer therapeutics
Published: September 22, 2025

Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Journal: Molecular cancer therapeutics
Published: September 22, 2025

Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study.

Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study.

Journal: HemaSphere
Published: September 05, 2025

BTKi + humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?

BTKi + humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?

Journal: Haematologica
Published: June 19, 2025

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Journal: Blood cancer journal
Published: June 13, 2025

Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.

Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.

Journal: Blood
Published: June 02, 2025

Prevalence and survival outcomes of adult T-cell leukemia/lymphoma in Latin America: A multicenter cohort study and recommendations to improve diagnosis and outcomes.

Prevalence and survival outcomes of adult T-cell leukemia/lymphoma in Latin America: A multicenter cohort study and recommendations to improve diagnosis and outcomes.

Journal: Cancer epidemiology
Published: May 13, 2025
Showing 1-12 of 209

Last Updated: 09/26/2026